“meningococcal vaccine”的搜索结果，显示 691-700 项，共有 11650 项

1. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

2. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the safety, maximum tolerated dose (MTD) and RP2D of ABBV-383 monotherapy for patients with RRWM and to determine ...

3. 血管中心- 临床试验- 妙佑医疗国际

   The primary objective of this proposal is to develop a Thoracic Specimen Registry at Mayo Clinic. The purpose of the registry will be to support ongoing ...

4. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

5. 揭穿与COVID-19 相关的不实传言

   该系统名为Vaccine Safety Datalink（疫苗安全数据链接系统），旨在快速发现需要关注的模式（也称为敏感性）。但经过审查，在报告卒中与接种COVID-19 疫苗之间未发现 ...

6. 放射科- 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The purpose of this study is to address a knowledge gap. Early diagnosis of nerve root avulsion injuries following brachial plexus trauma ...

7. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma ...

8. 外科 - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine whether transverse/sigmoid sinus junction stenting reduces the risk of recurrent cerebrospinal fluid ...

9. 放射科- 临床试验- 妙佑医疗国际

   The natural course of autosomal dominant polycystic kidney disease (ADPKD) is highly variable and typically characterized by progressive enlargement of ...

10. 心肌炎 - 症状与病因- 妙佑医疗国际

    Vaccine. 2021; doi:10.1016/j.vaccine.2021.05.087. Mevorach D, et al. Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. The New England ...